Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.1558 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.15416 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 1.96462 | 3 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.13075 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.61225 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.15427 | 6 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.16551 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.15729 | 8 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.11053 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.15603 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.15046 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.13665 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.15311 | 7 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.15485 | 7 |